MSP3-CRM-Vac4All/ Alhydrogel® Vaccine
Condition(s):Malaria,FalciparumLast Updated:April 26, 2023Recruiting
Include Studies Not Open or Pending
Condition(s):Malaria,FalciparumLast Updated:April 26, 2023Recruiting
Condition(s):Immune ResponseLast Updated:May 25, 2023Recruiting
Condition(s):HIVLast Updated:March 27, 2024Not yet recruiting
Condition(s):HIV InfectionsLast Updated:January 18, 2024Recruiting
Condition(s):HIVLast Updated:February 20, 2024Not yet recruiting
Condition(s):Hepatitis BLast Updated:March 5, 2024Recruiting
Condition(s):Type 1 Diabetes MellitusLast Updated:March 28, 2024Recruiting
Condition(s):Cervical Intraepithelial Neoplasia; Cervical Cancer; Vaginal Intraepithelial Neoplasia; Vulvar Intraepithelial Neoplasia; Persistent InfectionLast Updated:January 26, 2023Recruiting
Condition(s):Cervical Intraepithelial Neoplasia; Cervical Cancer; Vaginal Intraepithelial Neoplasia; Vulvar Intraepithelial Neoplasia; Persistent InfectionLast Updated:January 26, 2023Recruiting
Condition(s):Respiratory Syncytial Virus InfectionLast Updated:February 22, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.